Epigenetic Features of FoxP3 in Children With Cow's Milk Allergy
NCT ID: NCT02779881
Last Updated: 2016-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2012-12-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
DNA methylation is a biologically and chemically stable epigenetic modification that locks in long-term gene expression patterns. The demethylation status of FoxP3 at a highly conserved region within the Treg-specific-demethylated-region (TSDR), a CpG-rich, located on the 2nd conserved non-coding sequence of FoxP3 (CNS2), is restricted to Tregs. Transcriptional activity of the TSDR is essentially determined by its methylation status : it is completely inactive in its methylated state, but when the TSDR is demethylated, transcription factors such as Ets-1 and Creb can bind to the TSDR. TSDR demethylated and open chromatin conformation in the Foxp3 locus leads to stable phenotype differentiated Foxp3+ Treg. FoxP3 TSDR demethylation in peripheral blood mononuclear cells (PBMCs) has been associated with reduced atopic sensitization and asthma in children. Epigenetic regulation of antigen-induced T-cell subsets may predict a state of immune tolerance in food allergy. Indeed, DNA methylation of the FoxP3 gene in Tregs decreased during oral tolerance acquisition in patients with peanut allergy undergoing oral immunotherapy. The aim of this study was to evaluate further the epigenetic regulation of FoxP3 gene in children with IgE-mediated CMA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epigenetic Effects in Children With Cow's Milk Allergy Treated With Different Formulas
NCT04184700
Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy
NCT01634490
Step Down Approach in Children With Cow Milk Allergy
NCT03449537
Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy
NCT01622426
Tolerability of Hypoallergenic Formula in Children With Cow's Milk Allergy
NCT03909113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy controls
Healthy controls
No interventions assigned to this group
Children at diagnosis of cow's milk allergy
Children at diagnosis of cow's milk allergy
No interventions assigned to this group
Subjects outgrown cow's milk allergy with formula+probiotic
Tolerant with extensively hydrolyzed casein formula with Lactobacillus rhamnosus GG
Extensively hydrolyzed casein formula plus LGG
Subjects outgrown cow's milk allergy assuming other formulas
Subjects tolerant with other formulas
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extensively hydrolyzed casein formula plus LGG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* eosinophilic disorders of the gastrointestinal tract
* food protein-induced enterocolitis syndrome
* concomitant chronic systemic diseases
* congenital cardiac defects
* active tuberculosis
* autoimmune diseases
* immunodeficiency
* chronic inflammatory bowel diseases
* celiac disease
* cystic fibrosis
* metabolic diseases
* lactose intolerance
* malignancy
* chronic pulmonary diseases
* malformations of the gastrointestinal tract
3 Months
18 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberto Berni Canani
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Naples Federico II
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Paparo L, Nocerino R, Cosenza L, Aitoro R, D'Argenio V, Del Monaco V, Di Scala C, Amoroso A, Di Costanzo M, Salvatore F, Berni Canani R. Epigenetic features of FoxP3 in children with cow's milk allergy. Clin Epigenetics. 2016 Aug 12;8:86. doi: 10.1186/s13148-016-0252-z. eCollection 2016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.